Regulation - GlaxoSmithKline, Gastro-intestinals

Filter

Popular Filters

FDA filings for Ironwood and Forest for linaclotide, and GSK and XenoPort for Horizant ER

10-08-2011

US drugmakers Ironwood Pharmaceuticals (Nasdaq: IRWD) and Forest Laboratories (NYSE: FRX) have submitted…

Forest LaboratoriesGastro-intestinalsGlaxoSmithKlineHorizantIronwood PharmaceuticalslinaclotideNeurologicalNorth AmericaPharmaceuticalRegulationXenoPort

Back to top